Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
SAF Farma Georgia — the Georgian arm (since 2015) of SAF Farma, a pharmaceutical marketing and brand-representation group founded in Azerbaijan in 2004 and also active in Ukraine and Uzbekistan (saffarma.ge). Imports and markets innovative branded medications across ophthalmology, therapy, neurology, gynaecology and paediatrics.
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,337 | 3,639 | 3,453 | 5,879 | 6,628 | 6,454 | 6,369 | +18.2% |
| Total COGS | 1,534 | 1,454 | 1,261 | 2,669 | 2,601 | 2,369 | 2,548 | +8.8% |
| Gross Profit | 803 | 2,184 | 2,192 | 3,210 | 4,026 | 4,085 | 3,822 | +29.7% |
| Gross Margin | 34.4% | 60.0% | 63.5% | 54.6% | 60.8% | 63.3% | 60.0% | |
| 473 | 700 | 1,335 | 1,843 | 2,990 | 2,898 | 2,387 | +31.0% | |
| EBITDA | 330 | 1,485 | 857 | 1,367 | 1,037 | 1,187 | 1,435 | +27.8% |
| EBITDA Margin | 14.1% | 40.8% | 24.8% | 23.3% | 15.6% | 18.4% | 22.5% | |
| Total D&A | 12 | 14 | 15 | 15 | 9 | 0 | 0 | -5.4% |
| EBIT / Operating Income | 318 | 1,470 | 842 | 1,352 | 1,027 | 1,187 | 1,435 | +28.5% |
| 5 | 0 | 0 | 0 | 133 | 47 | 29 | +31.8% | |
| Profit Before Tax | 324 | 1,470 | 842 | 1,352 | 894 | 1,140 | 1,464 | +28.6% |
| Total Income Tax | 49 | 221 | 591 | 390 | 424 | 0 | 0 | +71.9% |
| Net Profit / (Loss) | 275 | 1,250 | 251 | 962 | 470 | 1,140 | 1,464 | +32.1% |
| Net Margin | 11.8% | 34.3% | 7.3% | 16.4% | 7.1% | 17.7% | 23.0% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →